← Back to Search

Procedure

Cholangioscopy for Gallstone Disease

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes to 2.5 hours anticipated time frame
Awards & highlights

Summary

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.

Eligible Conditions
  • Gallstone Disease
  • Biliary Obstruction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 weeks post-procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 weeks post-procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Stone clearance
Secondary outcome measures
Procedure Duration
Other outcome measures
Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: CholangioscopyExperimental Treatment2 Interventions
Participants in this arm undergo radiation-free ERCP facilitated by cholangioscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cholangioscopy
2015
N/A
~40
Spyglass DS Cholangioscope
2015
N/A
~40

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,354 Total Patients Enrolled
Boston Scientific CorporationIndustry Sponsor
737 Previous Clinical Trials
854,196 Total Patients Enrolled
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top